Stable expression of MutLγ in human cells reveals no specific response to mismatched DNA, but distinct recruitment to damage sites

Journal of Cellular Biochemistry

Volumn 114, Issue 10, 2013, Pages 2405-2414

  Roesner, Lennart M ^a   Mielke, Christian ^b   Fähnrich, Silke ^a   Merkhoffer, Yvonne ^a   Dittmar, Kurt E J ^c   Drexler, Hans G ^a   Dirks, Wilhelm G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

DNA ALKYLATION DAMAGE; DNA DAMAGE RECRUITMENT; DNA DAMAGE RESPONSE (DDR); DNA MISMATCH REPAIR (MMR); MLH3; UV MICRO IRRADIATION

Indexed keywords

DIMER; DNA; GREEN FLUORESCENT PROTEIN; HETERODIMER; MISMATCH REPAIR PROTEIN PMS2; PROTEIN; PROTEIN MLH1; PROTEIN MLH3; PROTEIN MUTL; PROTEIN MUTL GAMMA; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN MLH1; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; ASSAY; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET A RADIATION;

EID: 84882414345     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24591     Document Type: Article

References (54)

1. Akiyama Y, Nagasaki H, Nakajima T, Sakai H, Nomizu T, Yuasa Y,. 2001. Infrequent frameshift mutations in the simple repeat sequences of hMLH3 in hereditary nonpolyposis colorectal cancers. Jpn J Clin Oncol 31: 61-64.
2. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG,. 2006. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354: 2751-2763.
3. Brieger A, Plotz G, Raedle J, Weber N, Baum W, Caspary WF, Zeuzem S, Trojan J,. 2005. Characterization of the nuclear import of human MutLalpha. Mol Carcinog 43: 51-58.
4. Brieger A, Plotz G, Hinrichsen I, Passmann S, Adam R, Zeuzem S,. 2012. C-terminal fluorescent labeling impairs functionality of DNA mismatch repair proteins. PLoS ONE 7: e31863.
5. Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML,. 2009. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 58: 661-667.
6. Cannavo E, Marra G, Sabates-Bellver J, Menigatti M, Lipkin SM, Fischer F, Cejka P, Jiricny J,. 2005. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res 65: 10759-10766.
7. Cannavo E, Gerrits B, Marra G, Schlapbach R, Jiricny J,. 2007. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J Biol Chem 282: 2976-2986.
8. Cejka P, Stojic L, Mojas N, Russell AM, Heinimann K, Cannavo E, di Pietro M, Marra G, Jiricny J,. 2003. Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J 22: 2245-2254.
9. Celis JE, Celis A,. 1985. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci USA 82: 3262-3266.
10. Charbonneau N, Amunugama R, Schmutte C, Yoder K, Fishel R,. 2009. Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair. Cancer Biol Ther 8: 1411-1420.
11. Chen PC, Dudley S, Hagen W, Dizon D, Paxton L, Reichow D, Yoon SR, Yang K, Arnheim N, Liskay RM, Lipkin SM,. 2005. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Cancer Res 65: 8662-8670.
12. Chen PC, Kuraguchi M, Velasquez J, Wang Y, Yang K, Edwards R, Gillen D, Edelmann W, Kucherlapati R, Lipkin SM,. 2008. Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression. PLoS Genet 4: e1000092.
13. Cohen PE, Pollack SE, Pollard JW,. 2006. Genetic analysis of chromosome pairing, recombination, and cell cycle control during first meiotic prophase in mammals. Endocr Rev 27: 398-426.
14. de Jong MM, Hofstra RM, Kooi KA, Westra JL, Berends MJ, Wu Y, Hollema H, van der Sluis T, van der Graaf WT, de Vries EG, Schaapveld M, Sijmons RH, te Meerman GJ, Kleibeuker JH,. 2004. No association between two MLH3 variants (S845G and P844L) and colorectal cancer risk. Cancer Genet Cytogenet 152: 70-71.
15. Dirks W, Wirth M, Hauser H,. 1993. Dicistronic transcription units for gene expression in mammalian cells. Gene 128: 247-249.
16. Dirks WG, Faehnrich S, Estella IA, Drexler HG,. 2005. Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. ALTEX 22: 103-109.
17. Flores-Rozas H, Kolodner RD,. 1998. The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations. Proc Natl Acad Sci USA 95: 12404-12409.
18. Helma C, Uhl M,. 2000. A public domain image-analysis program for the single-cell gel-electrophoresis (comet) assay. Mutat Res 466: 9-15.
19. Hienonen T, Laiho P, Salovaara R, Mecklin JP, Jarvinen H, Sistonen P, Peltomaki P, Lehtonen R, Nupponen NN, Launonen V, Karhu A, Aaltonen LA,. 2003. Little evidence for involvement of MLH3 in colorectal cancer predisposition. Int J Cancer 106: 292-296.
20. Hong Z, Jiang J, Hashiguchi K, Hoshi M, Lan L, Yasui A,. 2008. Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J Cell Sci 121: 3146-3154.
21. Iyer RR, Pluciennik A, Burdett V, Modrich PL,. 2006. DNA mismatch repair: Functions and mechanisms. Chem Rev 106: 302-323.
22. Jacobs JP, Jones CM, Baille JP,. 1970. Characteristics of a human diploid cell designated MRC-5. Nature 227: 168-170.
23. Jiricny J,. 2006. The multifaceted mismatch-repair system. Nature reviews. Mol Cell Biol 7: 335-346.
24. Kadyrov FA, Dzantiev L, Constantin N, Modrich P,. 2006. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126: 297-308.
25. Karran P, Marinus MG,. 1982. Mismatch correction at O6-methylguanine residues in E. coli DNA. Nature 296: 868-869.
26. Kleczkowska HE, Marra G, Lettieri T, Jiricny J,. 2001. hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes Dev 15: 724-736.
27. Knizhnik AV, Roos WP, Nikolova T, Quiros S, Tomaszowski KH, Christmann M, Kaina B,. 2013. Survival and death strategies in glioma cells: Autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage. PLoS ONE 8: e55665.
28. Kolas NK, Svetlanov A, Lenzi ML, Macaluso FP, Lipkin SM, Liskay RM, Greally J, Edelmann W, Cohen PE,. 2005. Localization of MMR proteins on meiotic chromosomes in mice indicates distinct functions during prophase I. J Cell Biol 171: 447-458.
29. Lipkin SM, Wang V, Jacoby R, Banerjee-Basu S, Baxevanis AD, Lynch HT, Elliott RM, Collins FS,. 2000. MLH3: A DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet 24: 27-35.
30. Lipkin SM, Moens PB, Wang V, Lenzi M, Shanmugarajah D, Gilgeous A, Thomas J, Cheng J, Touchman JW, Green ED, Schwartzberg P, Collins FS, Cohen PE,. 2002. Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet 31: 385-390.
31. Liu HX, Zhou XL, Liu T, Werelius B, Lindmark G, Dahl N, Lindblom A,. 2003. The role of hMLH3 in familial colorectal cancer. Cancer Res 63: 1894-1899.
32. Loukola A, Vilkki S, Singh J, Launonen V, Aaltonen LA,. 2000. Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer. Am J Pathol 157: 347-352.
33. Lynch HT, Smyrk T, Lynch J,. 1997. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 93: 84-99.
34. Lynch HT, Lynch JF, Attard TA,. 2009. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ 181: 273-280.
35. Mielke C, Tummler M, Schubeler D, von Hoegen I, Hauser H,. 2000. Stabilized, long-term expression of heterodimeric proteins from tricistronic mRNA. Gene 254: 1-8.
36. Mielke C, Kalfalah FM, Christensen MO, Boege F,. 2007. Rapid and prolonged stalling of human DNA topoisomerase I in UVA-irradiated genomic areas. DNA Repair 6: 1757-1763.
37. Mojas N, Lopes M, Jiricny J,. 2007. Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev 21: 3342-3355.
38. Mortusewicz O, Leonhardt H,. 2007. XRCC1 and PCNA are loading platforms with distinct kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol Biol 8: 81.
39. Mortusewicz O, Leonhardt H, Cardoso MC,. 2008. Spatiotemporal dynamics of regulatory protein recruitment at DNA damage sites. J Cell Biochem 104: 1562-1569.
40. Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, Niessen RC, Eggen BJ, Nielsen FC, Kleibeuker JH, Sijmons RH, Rasmussen LJ, Hofstra RM,. 2009. Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome. Genes Chromosomes Cancer 48: 340-350.
41. Peltomaki P,. 2003. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 21: 1174-1179.
42. Pillon MC, Lorenowicz JJ, Uckelmann M, Klocko AD, Mitchell RR, Chung YS, Modrich P, Walker GC, Simmons LA, Friedhoff P, Guarne A,. 2010. Structure of the endonuclease domain of MutL: Unlicensed to cut. Mol Cell 39: 145-151.
43. Pillon MC, Miller JH, Guarne A,. 2011. The endonuclease domain of MutL interacts with the beta sliding clamp. DNA Repair 10: 87-93.
44. Quiros S, Roos WP, Kaina B,. 2010. Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle 9: 168-178.
45. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM,. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
46. Rogakou EP, Boon C, Redon C, Bonner WM,. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146: 905-916.
47. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML,. 2001. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121: 830-838.
48. Santucci-Darmanin S, Neyton S, Lespinasse F, Saunieres A, Gaudray P, Paquis-Flucklinger V,. 2002. The DNA mismatch-repair MLH3 protein interacts with MSH4 in meiotic cells, supporting a role for this MutL homolog in mammalian meiotic recombination. Hum Mol Genet 11: 1697-1706.
49. Snapp EL, Altan N, Lippincott-Schwartz J,. 2003. Measuring protein mobility by photobleaching GFP chimeras in living cells. Curr Protoc Cell Biol 19: 21.1.1-21.1.24.
50. Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J,. 2004. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev 18: 1331-1344.
51. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S,. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268.
52. Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, van der Sluis T, Kempinga C, van dDer Zee AG, Hollema H, Buys CH, Kleibeuker JH, Hofstra RM,. 2001. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 29: 137-138.
53. Zakharyevich K, Ma Y, Tang S, Hwang PY, Boiteux S, Hunter N,. 2010. Temporally and biochemically distinct activities of Exo1 during meiosis: Double-strand break resection and resolution of double Holliday junctions. Mol Cell 40: 1001-1015.
54. Zakharyevich K, Tang S, Ma Y, Hunter N,. 2012. Delineation of joint molecule resolution pathways in meiosis identifies a crossover-specific resolvase. Cell 149: 334-347.